Table of Contents Executive Summary 1 Industry Overview of Conjugate Vaccines 1.1 Definition of Conjugate Vaccines 1.2 Conjugate Vaccines Segment By type 1.2.1 Global Conjugate Vaccines Production Growth Rate Comparison By type (2014-2025) 1.2.2 Monovalent Conjugate Vaccines 1.2.3 Multivalent Conjugate Vaccines 1.3 Conjugate Vaccines Segment by Applications 1.3.1 Global Conjugate Vaccines Consumption Comparison by Applications (2014-2025) 1.3.2 Pediatrics 1.3.3 Adults 1.4 Global Conjugate Vaccines Overall Market 1.4.1 Global Conjugate Vaccines Revenue (2014-2025) 1.4.2 Global Conjugate Vaccines Production (2014-2025) 1.4.3 North America Conjugate Vaccines Status and Prospect (2014-2025) 1.4.4 Europe Conjugate Vaccines Status and Prospect (2014-2025) 1.4.5 China Conjugate Vaccines Status and Prospect (2014-2025) 1.4.6 Japan Conjugate Vaccines Status and Prospect (2014-2025) 1.4.7 Southeast Asia Conjugate Vaccines Status and Prospect (2014-2025) 1.4.8 India Conjugate Vaccines Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Conjugate Vaccines 2.3 Manufacturing Process Analysis of Conjugate Vaccines 2.4 Industry Chain Structure of Conjugate Vaccines 3 Development and Manufacturing Plants Analysis of Conjugate Vaccines 3.1 Capacity and Commercial Production Date 3.2 Global Conjugate Vaccines Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of Conjugate Vaccines 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 Conjugate Vaccines Production and Capacity Analysis 4.2 Conjugate Vaccines Revenue Analysis 4.3 Conjugate Vaccines Price Analysis 4.4 Market Concentration Degree 5 Conjugate Vaccines Regional Market Analysis 5.1 Conjugate Vaccines Production by Regions 5.1.1 Global Conjugate Vaccines Production by Regions 5.1.2 Global Conjugate Vaccines Revenue by Regions 5.2 Conjugate Vaccines Consumption by Regions 5.3 North America Conjugate Vaccines Market Analysis 5.3.1 North America Conjugate Vaccines Production 5.3.2 North America Conjugate Vaccines Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Conjugate Vaccines Import and Export 5.4 Europe Conjugate Vaccines Market Analysis 5.4.1 Europe Conjugate Vaccines Production 5.4.2 Europe Conjugate Vaccines Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe Conjugate Vaccines Import and Export 5.5 China Conjugate Vaccines Market Analysis 5.5.1 China Conjugate Vaccines Production 5.5.2 China Conjugate Vaccines Revenue 5.5.3 Key Manufacturers in China 5.5.4 China Conjugate Vaccines Import and Export 5.6 Japan Conjugate Vaccines Market Analysis 5.6.1 Japan Conjugate Vaccines Production 5.6.2 Japan Conjugate Vaccines Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan Conjugate Vaccines Import and Export 5.7 Southeast Asia Conjugate Vaccines Market Analysis 5.7.1 Southeast Asia Conjugate Vaccines Production 5.7.2 Southeast Asia Conjugate Vaccines Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia Conjugate Vaccines Import and Export 5.8 India Conjugate Vaccines Market Analysis 5.8.1 India Conjugate Vaccines Production 5.8.2 India Conjugate Vaccines Revenue 5.8.3 Key Manufacturers in India 5.8.4 India Conjugate Vaccines Import and Export 6 Conjugate Vaccines Segment Market Analysis (by Type) 6.1 Global Conjugate Vaccines Production by Type 6.2 Global Conjugate Vaccines Revenue by Type 6.3 Conjugate Vaccines Price by Type 7 Conjugate Vaccines Segment Market Analysis (by Application) 7.1 Global Conjugate Vaccines Consumption by Application 7.2 Global Conjugate Vaccines Consumption Market Share by Application (2014-2019) 8 Conjugate Vaccines Major Manufacturers Analysis 8.1 Novartis 8.1.1 Novartis Conjugate Vaccines Production Sites and Area Served 8.1.2 Novartis Product Introduction, Application and Specification 8.1.3 Novartis Conjugate Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 Neuron Biotech 8.2.1 Neuron Biotech Conjugate Vaccines Production Sites and Area Served 8.2.2 Neuron Biotech Product Introduction, Application and Specification 8.2.3 Neuron Biotech Conjugate Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 Serum Institute of India 8.3.1 Serum Institute of India Conjugate Vaccines Production Sites and Area Served 8.3.2 Serum Institute of India Product Introduction, Application and Specification 8.3.3 Serum Institute of India Conjugate Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 Pfizer 8.4.1 Pfizer Conjugate Vaccines Production Sites and Area Served 8.4.2 Pfizer Product Introduction, Application and Specification 8.4.3 Pfizer Conjugate Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 8.5 Sanofi Pasteur 8.5.1 Sanofi Pasteur Conjugate Vaccines Production Sites and Area Served 8.5.2 Sanofi Pasteur Product Introduction, Application and Specification 8.5.3 Sanofi Pasteur Conjugate Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.5.4 Main Business and Markets Served 8.6 Bharat Biotech 8.6.1 Bharat Biotech Conjugate Vaccines Production Sites and Area Served 8.6.2 Bharat Biotech Product Introduction, Application and Specification 8.6.3 Bharat Biotech Conjugate Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.6.4 Main Business and Markets Served 8.7 Biological 8.7.1 Biological Conjugate Vaccines Production Sites and Area Served 8.7.2 Biological Product Introduction, Application and Specification 8.7.3 Biological Conjugate Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.7.4 Main Business and Markets Served 8.8 GlaxoSmithKline 8.8.1 GlaxoSmithKline Conjugate Vaccines Production Sites and Area Served 8.8.2 GlaxoSmithKline Product Introduction, Application and Specification 8.8.3 GlaxoSmithKline Conjugate Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.8.4 Main Business and Markets Served 8.9 Merck 8.9.1 Merck Conjugate Vaccines Production Sites and Area Served 8.9.2 Merck Product Introduction, Application and Specification 8.9.3 Merck Conjugate Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.9.4 Main Business and Markets Served 8.10 CSL 8.10.1 CSL Conjugate Vaccines Production Sites and Area Served 8.10.2 CSL Product Introduction, Application and Specification 8.10.3 CSL Conjugate Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.10.4 Main Business and Markets Served 9 Development Trend of Analysis of Conjugate Vaccines Market 9.1 Global Conjugate Vaccines Market Trend Analysis 9.1.1 Global Conjugate Vaccines Market Size (Volume and Value) Forecast 2019-2025 9.2 Conjugate Vaccines Regional Market Trend 9.2.1 North America Conjugate Vaccines Forecast 2019-2025 9.2.2 Europe Conjugate Vaccines Forecast 2019-2025 9.2.3 China Conjugate Vaccines Forecast 2019-2025 9.2.4 Japan Conjugate Vaccines Forecast 2019-2025 9.2.5 Southeast Asia Conjugate Vaccines Forecast 2019-2025 9.2.6 India Conjugate Vaccines Forecast 2019-2025 9.3 Conjugate Vaccines Market Trend (Product Type) 9.4 Conjugate Vaccines Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 Conjugate Vaccines Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of Conjugate Vaccines Table Global Conjugate Vaccines Production (K Doses) Growth Rate Comparison by Types (2014-2025) Figure Global Conjugate Vaccines Production Market Share by Types in 2018 Figure Monovalent Conjugate Vaccines Product Picture Figure Multivalent Conjugate Vaccines Product Picture Table Global Conjugate Vaccines Consumption (K Doses) Comparison by Applications (2014-2025) Figure Global Conjugate Vaccines Consumption Market Share by Applications in 2018 Figure Pediatrics Figure Adults Figure Global Conjugate Vaccines Revenue (Million USD) (2014-2025) Figure Global Conjugate Vaccines Production (K Doses) (2014-2025) Figure North America Conjugate Vaccines Market Size (Million USD) (2014-2025) Figure Europe Conjugate Vaccines Market Size (Million USD) (2014-2025) Figure China Conjugate Vaccines Market Size (Million USD) (2014-2025) Figure Japan Conjugate Vaccines Market Size (Million USD) (2014-2025) Figure Southeast Asia Conjugate Vaccines Market Size (Million USD) (2014-2025) Figure India Conjugate Vaccines Market Size (Million USD) (2014-2025) Table Conjugate Vaccines Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Conjugate Vaccines in 2018 Figure Manufacturing Process Analysis of Conjugate Vaccines Figure Industry Chain Structure of Conjugate Vaccines Table Capacity and Commercial Production Date of Key Manufacturers Table Global Conjugate Vaccines Manufacturing Plants Distribution Table Conjugate Vaccines Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table Conjugate Vaccines Capacity (K Doses) of Major Manufacturers (2014-2019) Table Conjugate Vaccines Production (K Doses) of Major Manufacturers (2014-2019) Table Conjugate Vaccines Production Market Share of Major Manufacturers (2014-2019) Figure Conjugate Vaccines Production Share by Manufacturers in 2018 Table Conjugate Vaccines Revenue (Million US$) of Major Manufacturers (2014-2019) Table Conjugate Vaccines Revenue Market Share of Major Manufacturers (2014-2019) Figure Conjugate Vaccines Revenue Share by Manufacturers in 2018 Table Conjugate Vaccines Average Price (USD/Doses) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global Conjugate Vaccines Production by Regions 2014-2019 (K Doses) Table Global Conjugate Vaccines Production Market Share by Regions 2014-2019 Figure Global Conjugate Vaccines Production Market Share by Regions in 2018 Table Global Conjugate Vaccines Revenue by Regions 2014-2019 (Million USD) Table Global Conjugate Vaccines Revenue Market Share by Regions 2014-2019 Figure Global Conjugate Vaccines Revenue Market Share by Regions in 2018 Table Global Conjugate Vaccines Consumption by Regions 2014-2019 (K Doses) Table Global Conjugate Vaccines Consumption Market Share by Regions 2014-2019 Figure North America Conjugate Vaccines Production Growth Rate 2014-2019 (K Doses) Figure North America Conjugate Vaccines Revenue Growth Rate 2014-2019 (Million USD) Table North America Conjugate Vaccines Production, Consumption Import and Export (K Doses) Figure Europe Conjugate Vaccines Production Growth Rate 2014-2019 (K Doses) Figure Europe Conjugate Vaccines Revenue Growth Rate 2014-2019 (Million USD) Table Europe Conjugate Vaccines Production, Consumption Import and Export (K Doses) Figure China Conjugate Vaccines Production Growth Rate 2014-2019 (K Doses) Figure China Conjugate Vaccines Revenue Growth Rate 2014-2019 (Million USD) Table China Conjugate Vaccines Production, Consumption Import and Export (K Doses) Figure Japan Conjugate Vaccines Production Growth Rate 2014-2019 (K Doses) Figure Japan Conjugate Vaccines Revenue Growth Rate 2014-2019 (Million USD) Table Japan Conjugate Vaccines Production, Consumption Import and Export (K Doses) Figure Southeast Asia Conjugate Vaccines Production Growth Rate 2014-2019 (K Doses) Figure Southeast Asia Conjugate Vaccines Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia Conjugate Vaccines Production, Consumption Import and Export (K Doses) Figure India Conjugate Vaccines Production Growth Rate 2014-2019 (K Doses) Figure India Conjugate Vaccines Revenue Growth Rate 2014-2019 (Million USD) Table India Conjugate Vaccines Production, Consumption Import and Export (K Doses) Figure Global Consumption Conjugate Vaccines Market Share by Application (2014-2019) Figure Global Value (Consumption) Conjugate Vaccines Market Share by Application (2014-2019) Table Novartis Conjugate Vaccines Production Sites and Area Served Table Novartis Conjugate Vaccines Product Introduction, Application and Specification Table Novartis Conjugate Vaccines Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Doses) and Gross Margin (2014-2019) Table Novartis Conjugate Vaccines Production Growth Rate (2014-2019) Table Novartis Conjugate Vaccines Production Market Share (2014-2019) Figure Novartis Conjugate Vaccines Revenue Market Share (2014-2019) Table Novartis Conjugate Vaccines Main Business and Markets Served Table Neuron Biotech Conjugate Vaccines Production Sites and Area Served Table Neuron Biotech Conjugate Vaccines Product Introduction, Application and Specification Table Neuron Biotech Conjugate Vaccines Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Doses) and Gross Margin (2014-2019) Table Neuron Biotech Conjugate Vaccines Production Growth Rate (2014-2019) Table Neuron Biotech Conjugate Vaccines Production Market Share (2014-2019) Figure Neuron Biotech Conjugate Vaccines Revenue Market Share (2014-2019) Table Neuron Biotech Conjugate Vaccines Main Business and Markets Served Table Serum Institute of India Conjugate Vaccines Production Sites and Area Served Table Serum Institute of India Conjugate Vaccines Product Introduction, Application and Specification Table Serum Institute of India Conjugate Vaccines Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Doses) and Gross Margin (2014-2019) Table Serum Institute of India Conjugate Vaccines Production Growth Rate (2014-2019) Table Serum Institute of India Conjugate Vaccines Production Market Share (2014-2019) Figure Serum Institute of India Conjugate Vaccines Revenue Market Share (2014-2019) Table Serum Institute of India Conjugate Vaccines Main Business and Markets Served Table Pfizer Conjugate Vaccines Production Sites and Area Served Table Pfizer Conjugate Vaccines Product Introduction, Application and Specification Table Pfizer Conjugate Vaccines Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Doses) and Gross Margin (2014-2019) Table Pfizer Conjugate Vaccines Production Growth Rate (2014-2019) Table Pfizer Conjugate Vaccines Production Market Share (2014-2019) Figure Pfizer Conjugate Vaccines Revenue Market Share (2014-2019) Table Pfizer Conjugate Vaccines Main Business and Markets Served Table Sanofi Pasteur Conjugate Vaccines Production Sites and Area Served Table Sanofi Pasteur Conjugate Vaccines Product Introduction, Application and Specification Table Sanofi Pasteur Conjugate Vaccines Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Doses) and Gross Margin (2014-2019) Table Sanofi Pasteur Conjugate Vaccines Production Growth Rate (2014-2019) Table Sanofi Pasteur Conjugate Vaccines Production Market Share (2014-2019) Figure Sanofi Pasteur Conjugate Vaccines Revenue Market Share (2014-2019) Table Sanofi Pasteur Conjugate Vaccines Main Business and Markets Served Table Bharat Biotech Conjugate Vaccines Production Sites and Area Served Table Bharat Biotech Conjugate Vaccines Product Introduction, Application and Specification Table Bharat Biotech Conjugate Vaccines Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Doses) and Gross Margin (2014-2019) Table Bharat Biotech Conjugate Vaccines Production Growth Rate (2014-2019) Table Bharat Biotech Conjugate Vaccines Production Market Share (2014-2019) Figure Bharat Biotech Conjugate Vaccines Revenue Market Share (2014-2019) Table Bharat Biotech Conjugate Vaccines Main Business and Markets Served Table Biological Conjugate Vaccines Production Sites and Area Served Table Biological Conjugate Vaccines Product Introduction, Application and Specification Table Biological Conjugate Vaccines Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Doses) and Gross Margin (2014-2019) Table Biological Conjugate Vaccines Production Growth Rate (2014-2019) Table Biological Conjugate Vaccines Production Market Share (2014-2019) Figure Biological Conjugate Vaccines Revenue Market Share (2014-2019) Table Biological Conjugate Vaccines Main Business and Markets Served Table GlaxoSmithKline Conjugate Vaccines Production Sites and Area Served Table GlaxoSmithKline Conjugate Vaccines Product Introduction, Application and Specification Table GlaxoSmithKline Conjugate Vaccines Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Doses) and Gross Margin (2014-2019) Table GlaxoSmithKline Conjugate Vaccines Production Growth Rate (2014-2019) Table GlaxoSmithKline Conjugate Vaccines Production Market Share (2014-2019) Figure GlaxoSmithKline Conjugate Vaccines Revenue Market Share (2014-2019) Table GlaxoSmithKline Conjugate Vaccines Main Business and Markets Served Table Merck Conjugate Vaccines Production Sites and Area Served Table Merck Conjugate Vaccines Product Introduction, Application and Specification Table Merck Conjugate Vaccines Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Doses) and Gross Margin (2014-2019) Table Merck Conjugate Vaccines Production Growth Rate (2014-2019) Table Merck Conjugate Vaccines Production Market Share (2014-2019) Figure Merck Conjugate Vaccines Revenue Market Share (2014-2019) Table Merck Conjugate Vaccines Main Business and Markets Served Table CSL Conjugate Vaccines Production Sites and Area Served Table CSL Conjugate Vaccines Product Introduction, Application and Specification Table CSL Conjugate Vaccines Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Doses) and Gross Margin (2014-2019) Table CSL Conjugate Vaccines Production Growth Rate (2014-2019) Table CSL Conjugate Vaccines Production Market Share (2014-2019) Figure CSL Conjugate Vaccines Revenue Market Share (2014-2019) Table CSL Conjugate Vaccines Main Business and Markets Served Figure Global Conjugate Vaccines Production (K Doses) Growth Rate Forecast 2019-2025 Figure Global Conjugate Vaccines Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global Conjugate Vaccines Sales Price (USD/Doses) Forecast 2019-2025 Figure North America Conjugate Vaccines Production Growth Rate Forecast 2019-2025 (K Doses) Figure North America Conjugate Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe Conjugate Vaccines Production Growth Rate Forecast 2019-2025 (K Doses) Figure Europe Conjugate Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China Conjugate Vaccines Production Growth Rate Forecast 2019-2025 (K Doses) Figure China Conjugate Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan Conjugate Vaccines Production Growth Rate Forecast 2019-2025 (K Doses) Figure Japan Conjugate Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia Conjugate Vaccines Production Growth Rate Forecast 2019-2025 (K Doses) Figure Southeast Asia Conjugate Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India Conjugate Vaccines Production Growth Rate Forecast 2019-2025 (K Doses) Figure India Conjugate Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (K Doses) of Conjugate Vaccines by Type (2019-2025) Table Global Consumption (K Doses) of Conjugate Vaccines by Application (2019-2025) Table Conjugate Vaccines Distributors List Table Conjugate Vaccines Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Novartis Neuron Biotech Serum Institute of India Pfizer Sanofi Pasteur Bharat Biotech Biological GlaxoSmithKline Merck CSL